Braintree Labs Company Profile
✉ Email this page to a colleague
What is the competitive landscape for BRAINTREE LABS
BRAINTREE LABS has two approved drugs.
There is one US patent protecting BRAINTREE LABS drugs.
Drugs and US Patents for Braintree Labs
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Braintree Labs | PIZENSY | lactitol | FOR SOLUTION;ORAL | 211281-001 | Feb 12, 2020 | DISCN | Yes | No | 10,806,743 | ⤷ Start Trial | ⤷ Start Trial | ||||
| Braintree Labs | SUCLEAR | magnesium sulfate; polyethylene glycol 3350; potassium chloride; potassium sulfate; sodium bicarbonate; sodium chloride; sodium sulfate | SOLUTION;ORAL | 203595-001 | Jan 18, 2013 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.

